iShares Biotechnology ETF $IBB Shares Bought by Erste Asset Management GmbH

Erste Asset Management GmbH grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 58.7% in the fourth quarter, HoldingsChannel reports. The fund owned 102,330 shares of the financial services provider’s stock after buying an additional 37,860 shares during the period. Erste Asset Management GmbH’s holdings in iShares Biotechnology ETF were worth $17,270,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in IBB. Dynamic Wealth Strategies LLC increased its stake in shares of iShares Biotechnology ETF by 16.6% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after acquiring an additional 60 shares during the period. Flagship Private Wealth LLC increased its stake in shares of iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after acquiring an additional 60 shares during the period. Larson Financial Group LLC increased its stake in shares of iShares Biotechnology ETF by 2.3% during the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock valued at $458,000 after acquiring an additional 60 shares during the period. Webster Bank N. A. increased its stake in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after acquiring an additional 62 shares during the period. Finally, Choreo LLC increased its stake in shares of iShares Biotechnology ETF by 2.2% during the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock valued at $514,000 after acquiring an additional 65 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.9%

NASDAQ IBB opened at $166.92 on Tuesday. iShares Biotechnology ETF has a 12 month low of $123.61 and a 12 month high of $179.64. The company’s 50 day simple moving average is $169.98 and its 200 day simple moving average is $170.59.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.